Pharmacodynamics of piperacillin/tazobactam against <i>Pseudomonas aeruginosa</i>: antibacterial effect and risk of emergence of resistance-Reference-Cited by-同舟云学术

Pharmacodynamics of piperacillin/tazobactam against Pseudomonas aeruginosa: antibacterial effect and risk of emergence of resistance

Published:2024-07-03 Issue:4 Volume:6 Page:
ISSN:2632-1823
Container-title:JAC-Antimicrobial Resistance
language:en
Short-container-title:

Author:

Carson Amy A¹^ORCID,Bowker Karen E²,Attwood Marie²,Noel Alan R²,MacGowan Alasdair P²

Affiliation:

1. Infection Sciences, Pathology Quarter, Southmead Hospital, Westbury-on-Trym , Bristol BS10 5NB , UK

2. Bristol Centre for Antimicrobial Research & Evaluation (BCARE), Severn Infection Sciences, Pathology Quarter, Southmead Hospital, Westbury-on-Trym , Bristol BS10 5NB , UK

Funder

North Bristol NHS Trust

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jacamr/article-pdf/6/4/dlae108/58875541/dlae108.pdf

Reference11 articles.

1. A survey of antibiotic administration practices involving patients with sepsis in UK critical care units;Barton;Int J Clin Pharm,2020

2. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles;Hoo;Indian J Med Microbiol,2017

3. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on β-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists;Lodise;Pharmacotherapy,2006

4. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?;Roberts;Clin Infect Dis,2014

5. Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR);Guilhaumou;Crit Care,2019